Hitting the Bullseye in Autoimmunity: Targeting Biologics through Tethering: Examining a Therapeutic Potential for Vitiligo and Beyond

J Invest Dermatol. 2022 Dec;142(12):3133-3135. doi: 10.1016/j.jid.2022.07.005. Epub 2022 Aug 26.

Authors

Olesya Plazyo¹, Johann E Gudjonsson²

Affiliations

¹ Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
² Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: johanng@med.umich.edu.

PMID: 36038402
DOI: 10.1016/j.jid.2022.07.005

No abstract available

Publication types

Comment

MeSH terms

Autoimmunity
Biological Products* / therapeutic use
Humans
Hypopigmentation*
Melanocytes
Vitiligo* / drug therapy

Substances

Biological Products

Grants and funding

P30 AR075043/AR/NIAMS NIH HHS/United States